Quincy, Illinois Clinical Trials

A listing of Quincy, Illinois clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 11 clinical trials
Study to Explore the Efficacy and Safety of BIO89-100 in Subjects With Severe Hypertriglyceridemia

This study is designed to assess the efficacy, safety, and tolerability of different doses and dose regimens (QW or every 2 weeks [Q2W]), subcutaneous (SC) dosing of BIO89-100 compared to placebo in subjects with Severe Hypertriglyceridemia (SHTG).

Quincy Medical Group
 (1.8 away) Contact site
  • 0 views
  • 05 Jun, 2021
  • +39 other locations
A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

This is a randomized, double-blind placebo-controlled multicenter phase 3 trial to evaluate the efficacy and safety of ARGX-113 in patients with primary ITP.

Investigator Site 0010035
 (0.9 away) Contact site
  • 28 views
  • 10 Jul, 2021
  • +241 other locations
A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer

The main purpose of this study is to measure how well abemaciclib works in participants with early breast cancer who are taking hormone therapy after surgery. Participants must have breast cancer that is hormone receptor positive (HR+) and human epidermal receptor 2 positive (HER2+). Your participation could last up to …

trastuzumab
erbb2
hormone therapy
HER2
pertuzumab
Quincy Medical Group
 (1.8 away) Contact site
  • 0 views
  • 28 Jul, 2021
  • +535 other locations
Study of First-line Pembrolizumab (MK-3475) With Lenvatinib (MK-7902/E7080) in Urothelial Carcinoma Cisplatin-ineligible Participants Whose Tumors Express Programmed Cell Death-Ligand 1 and in Participants Ineligible for Platinum-containing Chemotherapy (MK-7902-011/E7080-G000-317/ LEAP-011)

The purpose of this study is to evaluate the efficacy and safety of lenvatinib (MK-7902/E7080) in combination with pembrolizumab (MK-3475) in the treatment of cisplatin-ineligible participants with a Programmed Cell Death-Ligand 1 (PD-L1) Combined Positive Score (CPS) 10, or in participants ineligible for any platinum-containing chemotherapy regardless of CPS, with …

platinum-based chemotherapy
metastatic urothelial carcinoma
cancer
solid tumour
hearing loss
Quincy Medical Group ( Site 0022)
 (1.8 away) Contact site
  • 69 views
  • 01 Aug, 2021
  • +228 other locations
Study of ASTX727 vs IV Decitabine in MDS CMML and AML

Multicenter, randomized, open-label, crossover PK study of ASTX727 versus IV decitabine. Adult subjects who are candidates to receive IV decitabine will be randomized 1:1 to receive the ASTX727 tablet Daily5 in Cycle 1 followed by IV decitabine 20 mg/m^2 Daily5 in Cycle 2, or the converse order. After completion of …

secondary acute myeloid leukemia
direct bilirubin
conjugated bilirubin
blast cells
secondary aml
Quincy Medical Group
 (1.8 away) Contact site
  • 269 views
  • 27 Jan, 2021
  • +92 other locations
A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

This is a randomized, open-label, three-arm, phase 3 study in men with biochemically recurrent prostate cancer and PSA doubling time 9 months at the time of study entry.

gonadorelin
immunological adjuvant
prednisone
androgens
apalutamide
Quincy Medical Group
 (0.9 away) Contact site
  • 496 views
  • 23 Jan, 2021
  • +67 other locations
Efficacy and Safety of CUSA-081 in the Restoration of Central Venous Access Device (CVAD) Functionality

Study to evaluate the efficacy and safety of CUSA-081 in the restoration of central venous access device (CVAD) functionality in participants 18 years and older.

tissue plasminogen activator
alteplase
Chiesi Investigational Site
 (0.9 away) Contact site
  • 1 views
  • 27 Apr, 2021
  • +67 other locations
Radiofrequency (RF) Ablation Prospective Outcomes Study

The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems in the treatment of patients diagnosed with pain.

Quincy Medical Group
 (1.8 away) Contact site
  • 0 views
  • 16 Jul, 2021
  • +7 other locations
Connect Myeloid Disease Registry

The purpose of the Connect Myeloid disease registry is to provide unique insights into treatment decisions and treatment patterns as they relate to clinical outcomes of patients with myeloid diseases in routine clinical practice. This disease registry will also evaluate molecular and cellular markers that may provide further prognostic classification …

myeloid leukemia
leukemia
myelodysplastic syndromes
bone marrow procedure
myelofibrosis
Quincy Medical Group
 (1.8 away) Contact site
  • 2004 views
  • 10 Apr, 2021
  • +228 other locations
Palbociclib in Real World Practice

This Non-Interventional Study will describe and analyze the clinical use of palbociclib in routine clinical practice in the treatment of advanced breast cancer.

breast adenocarcinoma
palbociclib
breast cancer
advanced breast cancer
adenocarcinoma
Quincy Medical Group
 (1.8 away) Contact site
  • 2226 views
  • 01 Jun, 2021
  • +298 other locations